Page last updated: 2024-09-03

2-(n-myristoylamino)-1-phenyl-1-propanol and 1-phenyl-2-decanoylamino-3-morpholino-1-propanol

2-(n-myristoylamino)-1-phenyl-1-propanol has been researched along with 1-phenyl-2-decanoylamino-3-morpholino-1-propanol in 1 studies

Compound Research Comparison

Studies
(2-(n-myristoylamino)-1-phenyl-1-propanol)
Trials
(2-(n-myristoylamino)-1-phenyl-1-propanol)
Recent Studies (post-2010)
(2-(n-myristoylamino)-1-phenyl-1-propanol)
Studies
(1-phenyl-2-decanoylamino-3-morpholino-1-propanol)
Trials
(1-phenyl-2-decanoylamino-3-morpholino-1-propanol)
Recent Studies (post-2010) (1-phenyl-2-decanoylamino-3-morpholino-1-propanol)
2307230054

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Aloy, MT; Alphonse, G; Ardail, D; GĂ©rard, JP; Louisot, P; Rodriguez-Lafrasse, C; Rousson, R1

Other Studies

1 other study(ies) available for 2-(n-myristoylamino)-1-phenyl-1-propanol and 1-phenyl-2-decanoylamino-3-morpholino-1-propanol

ArticleYear
Increasing endogenous ceramide using inhibitors of sphingolipid metabolism maximizes ionizing radiation-induced mitochondrial injury and apoptotic cell killing.
    International journal of cancer, 2002, Oct-20, Volume: 101, Issue:6

    Topics: Apoptosis; Caspases; Cell Cycle; Ceramides; Dose-Response Relationship, Drug; Dose-Response Relationship, Radiation; Flow Cytometry; Glutathione; Humans; Imipramine; Jurkat Cells; Mitochondria; Morpholines; Myristates; Propanolamines; Radiation, Ionizing; Reactive Oxygen Species; Sphingolipids; Time Factors

2002